These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 14560238)

  • 1. Endovascular management of axillofemoral bypass graft stump syndrome.
    Kallakuri S; Ascher E; Hingorani A; Markewich N; Schutzer R; Hou A; Yorkovich W; Jacob T
    J Vasc Surg; 2003 Oct; 38(4):833-5. PubMed ID: 14560238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late upper extremity embolic complications of occluded axillofemoral grafts.
    Khalil IM; Hoballah JJ
    Ann Vasc Surg; 1991 Jul; 5(4):375-80. PubMed ID: 1878297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upper-extremity emboli secondary to axillofemoral graft thrombosis.
    Bandyk DF; Thiele BL; Radke HM
    Arch Surg; 1981 Apr; 116(4):393-5. PubMed ID: 7212997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upper extremity thromboembolism caused by occlusion of axillofemoral grafts.
    McLafferty RB; Taylor LM; Moneta GL; Yeager RA; Edwards JM; Porter JM
    Am J Surg; 1995 May; 169(5):492-5. PubMed ID: 7747826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contralateral brachial arterial access for endovascular treatment of recurrent axillofemoral bypass graft stump syndrome: A case report.
    Kim JJ; Kim DR; Chang JW
    Radiol Case Rep; 2023 Mar; 18(3):1277-1281. PubMed ID: 36691412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute disruption of polytetrafluoroethylene grafts adjacent to axillary anastomoses: a complication of axillofemoral grafting.
    Taylor LM; Park TC; Edwards JM; Yeager RA; McConnell DC; Moneta GA; Porter JM
    J Vasc Surg; 1994 Oct; 20(4):520-6; discussion 526-8. PubMed ID: 7933253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potential risk for upper extremity thromboembolism in patients with occluded axillofemoral bypass grafts: two case reports.
    Mawatari K; Muto Y; Funahashi S; Ikeda T; Komori K; Sugimachi K
    Vasc Surg; 2001; 35(1):67-71. PubMed ID: 11668372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endovascular treatment of an occluded axillofemoral bypass graft.
    Slovut DP; Bacharach JM
    Vasc Med; 2005 Feb; 10(1):33-6. PubMed ID: 15920998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcome after treatment of aortic graft infection with staged extra-anatomic bypass grafting and aortic graft removal.
    Seeger JM; Pretus HA; Welborn MB; Ozaki CK; Flynn TC; Huber TS
    J Vasc Surg; 2000 Sep; 32(3):451-9; discussion 460-1. PubMed ID: 10957651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Embolism of the humeral artery originating in a thrombosed axillo-femoral bypass].
    Barba A; Escribano JV; García-Alfageme A
    Angiologia; 1992; 44(3):107-9. PubMed ID: 1636926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent upper extremity acute limb ischemia secondary to retained axillary polytetrafluoroethylene cuff causing axillary stump syndrome.
    Fadoul MA; McMackin KK; Jonas L; Trani J
    J Vasc Surg Cases Innov Tech; 2020 Dec; 6(4):606-608. PubMed ID: 33150272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary aortoduodenal fistulas: value of initial axillofemoral bypass.
    Bergeron P; Espinoza H; Rudondy P; Ferdani M; Martin J; Jausseran JM; Courbier R
    Ann Vasc Surg; 1991 Jan; 5(1):4-7. PubMed ID: 1997073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unsuspected inflow disease in candidates for axillofemoral bypass operations: a prospective study.
    Calligaro KD; Ascer E; Veith FJ; Gupta SK; Wengerter KR; Franco CD; Bakal CW; Sprayregen S
    J Vasc Surg; 1990 Jun; 11(6):832-7. PubMed ID: 2359195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Axillofemoral bypass: outcome and hemodynamic results in high-risk patients.
    Schneider JR; McDaniel MD; Walsh DB; Zwolak RM; Cronenwett JL
    J Vasc Surg; 1992 Jun; 15(6):952-62; discussion 962-3. PubMed ID: 1597893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Axillofemoral bypass grafts using polytetrafluoroethylene.
    Alexander RH; Selby JH
    South Med J; 1980 Oct; 73(10):1325-9, 1332. PubMed ID: 6968977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeat axillofemoral grafting as treatment for axillofemoral graft occlusion.
    Olson CJ; Edwards JM; Taylor LM; Landry GJ; Yeager RA; Moneta GL
    Arch Surg; 2002 Dec; 137(12):1364-7; discussion 1367-8. PubMed ID: 12470102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative evaluation of externally supported Dacron and polytetrafluoroethylene prosthetic bypasses for femorofemoral and axillofemoral arterial reconstructions. Veterans Affairs Cooperative Study #141.
    Johnson WC; Lee KK
    J Vasc Surg; 1999 Dec; 30(6):1077-83. PubMed ID: 10587392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Debatable Choice of Iliac Inflow Source for Redo Femoropopliteal and Infrapopliteal Bypass.
    Gabrielli R; Ciocca F; Dante A; Musilli A; Maiorano M; Ventura M
    Ann Vasc Surg; 2018 Oct; 52():316.e15-316.e19. PubMed ID: 29886210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved patency after axillofemoral bypass for aortoiliac occlusive disease.
    Samson RH; Showalter DP; Lepore MR; Nair DG; Dorsay DA; Morales RE
    J Vasc Surg; 2018 Nov; 68(5):1430-1437. PubMed ID: 29691098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [High recurrence rate following axillofemoral bypass: is continued use still justified?].
    Hepp W; Pallua N
    Zentralbl Chir; 1985; 110(18):1138-46. PubMed ID: 4082804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.